GlobalData
AI Set to Improve Pharmaceutical R&D Productivity and Lower Costs, Says GlobalData
Jan. 13, 2025 -- Artificial intelligence (AI) has the potential to significantly reduce pharmaceutical R&D costs by streamlining drug discovery, optimizing clinical trials, and minimizing costly failures through data-driven ...Full Article
U.S., China Surge AI Venture Investment
Surprise! Venture capital funding in AI is heating up – sorry, continuing to heat up – hitting a record high in 2018, according to GlobalData, a data and analytics ...Full Article
